Dr. Charles Sawyers speaks at #AACR26 Plenary Session about overcoming resistance through an approach that addresses lineage plasticity in prostate and other tumors.

He recounted Enzalutamide, discussed elegant genetic mouse models of neuroendocrine prostate cancer involving